Geneva, Oct. 21 -- International Clinical Trials Registry received information related to the study (JPRN-jRCT1071250081) titled 'ASC4EDIT Japan(W-JHS CML01)' on Sept. 30.
Study Type: Observational
Primary Sponsor: Kikushige Yoshikane
Condition:
Chronic phase chronic myeloid leukemia
Chronic phase Chronic myeloid leukemia CML-CP
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 01/10/2025
Target Sample Size: 330
To know more, visit https://jrct.mhlw.go.jp/latest-detail/jRCT1071250081
Published by HT Digital Content Services with permission from Health Daily Digest....